Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UNVR | Common Stock | Award | $0 | +14.5K | +125.21% | $0.00 | 26K | Dec 31, 2022 | Direct | F1, F2 |
transaction | UNVR | Common Stock | Options Exercise | $0 | +3.68K | +14.16% | $0.00 | 29.7K | Dec 31, 2022 | Direct | F3 |
transaction | UNVR | Common Stock | Options Exercise | $0 | +3.52K | +11.86% | $0.00 | 33.2K | Dec 31, 2022 | Direct | F3 |
transaction | UNVR | Common Stock | Options Exercise | $0 | +1.45K | +4.38% | $0.00 | 34.7K | Dec 31, 2022 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | UNVR | Restricted Stock Units (RSUs)-7 | Options Exercise | $0 | -1.45K | -100% | $0.00* | 0 | Dec 31, 2022 | Common Stock | 1.45K | Direct | F3, F4 | |
transaction | UNVR | Restricted Stock Units -21 | Options Exercise | $0 | -3.68K | -49.99% | $0.00 | 3.68K | Dec 31, 2022 | Common Stock | 3.68K | Direct | F3, F5 | |
transaction | UNVR | Restricted Stock Units- 22 | Options Exercise | $0 | -3.52K | -33.33% | $0.00 | 7.05K | Dec 31, 2022 | Common Stock | 3.52K | Direct | F3, F6 |
Id | Content |
---|---|
F1 | The reported number of securities represents the settlement of the non-derivative PRSUs in shares of the Issuer's common stock following certification of performance goal attainment by the Compensation Committee on December 26,2022. The non-derivative PRSUs were granted in 2020, to be earned based on performance against predetermined Adjusted EBITDA and Return-on-Investment Capital performance goals during the three year period January 1, 2020 to December 31, 2022. The award was to be earned, if at all, upon the certification of performance goal attainment by the Compensation Committee following, and subject to the Reporting Persons continued employment through, the end of the performance period. |
F2 | Each non-derivative performance-restricted stock unit ("PRSU") represents a contingent right to receive, at settlement, one share of common stock upon vesting. This transaction represents the settlement of non-derivative PRSUs in shares of the Issuer's common stock following certification of performance goal attainment by the Compensation Committee on December 26, 2022. |
F3 | Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of the Issuer's common stock on a vesting date of December 31, 2022. |
F4 | On February 21, 2020, the reporting person was granted 4,360 restricted stock units, orginally vesting in three equal annual installments beginning on the first anniversary of the grant date, subject to the reporting person continuing to be employed by the issuer through each such date. |
F5 | On March 10, 2021, the reporting person was granted 11,050 restricted stock units, orginally vesting in three equal annual installments beginning on the first anniversary of the grant date, subject to the reporting person continuing to be employed by the issuer through each such date. |
F6 | On February 8, 2022, the reporting person was granted 10,570 restricted stock units, orginally vesting in three equal annual installments beginning on the first anniversary of the grant date, subject to the reporting person continuing to be employed by the issuer through each such date. |